Cargando…
Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
Aberrant activation of Wnt signaling has been implicated in human osteosarcoma, which may provide a genetic vulnerability that can be targeted in osteosarcoma treatment. To test whether Wnt activation is necessary for osteosarcoma growth, colony formation, invasion, and metastasis, we treated human...
Autores principales: | Fang, Fang, VanCleave, Ashley, Helmuth, Ralph, Torres, Haydee, Rickel, Kirby, Wollenzien, Hannah, Sun, Hongli, Zeng, Erliang, Zhao, Jing, Tao, Jianning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298399/ https://www.ncbi.nlm.nih.gov/pubmed/30613366 http://dx.doi.org/10.18632/oncotarget.26377 |
Ejemplares similares
-
Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway
por: VanCleave, Ashley, et al.
Publicado: (2020) -
Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma
por: Torres, Haydee M., et al.
Publicado: (2021) -
Precise detection of a murine germline mutation of the Notch3 gene associated with kyphosis and developmental disorders
por: Torres, Haydee M., et al.
Publicado: (2021) -
FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression
por: Guan, H, et al.
Publicado: (2015) -
Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway
por: Tan, Tao, et al.
Publicado: (2019)